Aberrant hypertrophy in Smad3-deficient murine chondrocytes is rescued by restoring transforming growth factor beta-activated kinase 1/activating transcription factor 2 signaling: a potential clinical implication for osteoarthritis.
Aberrant hypertrophy in Smad3-deficient murine chondrocytes is rescued by restoring transforming growth factor beta-activated kinase 1/activating transcription factor 2 signaling: a potential clinical implication for osteoarthritis.
复制标题
DOI:
10.1002/art.27537
复制
发表时间:
2010-08
影响因子:
--
通讯作者:
O'Keefe, Regis J.
中科院分区:
文献类型:
--
作者:
Li, Tian-Fang;Gao, Lin;Sheu, Tzong-Jen;Sampson, Erik R.;Flick, Lisa M.;Konttinen, Yrjo T.;Chen, Di;Schwarz, Edward M.;Zuscik, Michael J.;Jonason, Jennifer H.;O'Keefe, Regis J.
To investigate the biological significance of Smad3 in the progression of osteoarthritis (OA), the crosstalk between Smad3 and ATF-2 in the TGF-β signaling pathway, and the effects of ATF-2 overexpression and p38 activation in chondrocyte differentiation. Joint disease in Smad3 knockout (Smad3−/−) mice was examined by micro-CT and histology. Numerous in vitro methods including immunostaining, real-time PCR, Western blotting, an ATF-2 DNA-binding assay and a p38 kinase activity assay were used to study the various signaling responses and protein interactions underlying the altered chondrocyte phenotype in Smad3−/− mice. Smad3−/− mice gradually developed an end-stage OA phenotype. TGF-β-induced TAK1-ATF-2 signaling was disrupted in Smad3−/− chondrocytes at the level of p38 MAP kinase activation resulting in reduced ATF-2 phosphorylation and transcriptional activity. Re-introduction of Smad3 into the Smad3−/− cells restored the normal p38 response to TGF-β. Phospho-p38 formed a complex with Smad3 by binding to the Smad3 MH1-linker domains. Additionally, Smad3 inhibited the dephosphorylation of p38 by MAP kinase phosphatase-1 (MKP-1). Both ATF-2 overexpression and p38 activation repressed type X collagen expression in wild type and Smad3−/− chondrocytes. p38 was detected in articular cartilage and perichondrium; articular and sternal chondrocytes expressed p38 isoforms α, β and γ, but not δ. Smad3 is involved in both the onset and progression of OA. Loss of Smad3 abrogates TAK1-ATF-2 signaling, most likely by disrupting the Smad3-phospho-p38 complex and, thereby, promoting p38 dephosphorylation and inactivation by MKP-1. p38 and ATF-2 activation inhibit chondrocyte hypertrophy. Modulation of p38 isoform activity may provide a new therapeutic approach for OA.
登录
查看更多内容
DOI:
10.1073/pnas.0503617102
发表时间:
2005-12-13
影响因子:
11.1
作者:
Kobayashi, T;Lyons, KM;Kronenberg, HM
通讯作者:
Kronenberg, HM
影响因子:
4.8
作者:
Leivonen, SK;Chantry, A;Kähäri, VM
通讯作者:
Kähäri, VM
影响因子:
64.5
作者:
Alarcón C;Zaromytidou AI;Xi Q;Gao S;Yu J;Fujisawa S;Barlas A;Miller AN;Manova-Todorova K;Macias MJ;Sapkota G;Pan D;Massagué J
通讯作者:
Massagué J
影响因子:
3.7
作者:
Ionescu, AM;Schwarz, EM;O'Keefe, RJ
通讯作者:
O'Keefe, RJ
影响因子:
10.5
作者:
Breitwieser, Wolfgang;Lyons, Steve;Jones, Nic
通讯作者:
Jones, Nic